BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife”), a leading developer and supplier of bioproduction products and services, entered into an agreement to divest its wholly owned subsidiary, Global Cooling, Inc. ( “GCI” or “Stirling Ultracold”), to a select investor group.

GCI is an Ohio-based provider of environmentally friendly and energy efficient ultra-low temperature (“ULT”) freezers, utilized by a blue-chip customer base across numerous sectors, including biobanking, clinical trial, and cell and gene therapy.

BioLife Solutions, Inc. is leading supplier of cell processing tools and services for the CGT and broader biopharma markets. The Company’s expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage and distribution.

EC M&A served as exclusive financial advisor to BioLife on this transaction.